|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | An integratedchemical biology approach identifies specific vulnerabili-ty of Ewing's sarcoma to combined inhibition of Aurorakinases A and B显示文摘 | Winter G E Rix U Lissat A | 2011 | Mol Cancer Ther2011，10，10： | 1 |
| 2 | Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells显示文摘 | REMSING RIX LL RIX U COLINGE J | 2009 | Leukemia2009，23，3： | 1 |
| 3 | A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronicmyeloid leukemia cells显示文摘 | RIX U REMSING RIX L L TERKER A S | 2010 | Leukemia2010，24，1： | 1 |
| 4 | Synthesis, pharmacokinetics, efficacy, and rat retinal toxicity of a novel mitomycin C-triamcinolone acetortide conjugate显示文摘 | Macky TA Oelkers C Rix U Heredia ML Kfinzel E Wimberly M et oi | 2002 | J Med Chem2002，45，5： | 1 |
| 5 | Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets显示文摘 | RIX U HANTSCHEL O DURNBERGER G | 2007 | Blood2007，110，12： | 1 |
| 6 | A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib显示文摘 | Burkard TR Rix U Breitwieser FP | 2010 | PLoS Comput Biol2010，6，10： | 1 |
| 7 | Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML 显示文摘 | Winter GE Rix U Carlson SM | 2012 | Nat Chemi Biol2012，8，11： | 1 |
| 8 | Target profiling of small molecules by chemical proteomics显示文摘 | Rix U Superti-Furga G | 2009 | Nat Chem Biol2009，5，： | 1 |
| 9 | A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF显示文摘 | Borgdorff V Rix U Winter G E | 2014 | Oncogene2014，33，19： | 1 |
| 10 | Chemical proteomic profilesof the BCR -ABL inhibitors imatinib, nilotinib, and dasatinib revealnovel kinase and nonkinase targets显示文摘 | Rix U Hantschel O Dumberger G | 2007 | Blood2007，110，： | 1 |
| 11 | The btk tyrosine kinase is a major target of the bcr-abl inhibitor dasatinib 显示文摘 | Hantschel 0 Rix U Schmidt U | 2007 | Proc Natl Acad Sci2007，104，13： | 1 |
| 12 | A comprehensive target selec- tivity survey of the BCR- ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells 显示文摘 | Rix U Remsing L Terker S | 2010 | Leukemia2010，24，1： | 1 |
| 13 | Target profiling of small molecules by chemical proteomics 显示文摘 | Rix U Superti-Furga G | 2009 | Nat Chem Biol2009，5，： | 1 |
| 14 | Cytotoxic activities of new jadomycin derivatives 显示文摘 | Zheng J T Rix U Zhao L | 2005 | J Antibiot2005，58，： | 1 |
| 15 | A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells 显示文摘 | Rix U Remsing Rix L L Terker A S | 2010 | Leukemia2010，24，1： | 1 |
| 16 | Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets 显示文摘 | Rix U Hantschel O Durnberger G | 2007 | Blood2007，110，12： | 1 |
| 17 | Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib显示文摘 | Hantschel O Rix U Superti-Furga G | 2008 | Leuk Lymphoma2008，49，4： | 1 |
| 18 | The effects of dasatinib on IgE receptor-dependent activation and his- tamine release in human basophils显示文摘 | Kneidinger M Schmidt U Rix U | 2008 | Blood2008，111，6： | 1 |
| 19 | A chemical and phosphopro- teomic characterization of dasatinib action in lung cancer 显示文摘 | Li JN Rix U Fang B | 2010 | Nat Chem Biol2010，6，4： | 1 |
| 20 | A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALL显示文摘 | Rix U Colinge J Blatt K | | 0，，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员